September is Ovarian Cancer Awareness Month! The CARE Fund Board of Directors is proud to announce an exciting new partnership, the Rivkin Center/CARE Fund Award.

The Rivkin Center and the Andy Hill Cancer Research Endowment (CARE) Fund will jointly invest $1M in ovarian cancer research in Washington state, creating a pioneering public-private partnership. Because state and private investments are matched dollar for dollar, applicants are not required to provide a separate match. The partnership will create a replicable model for other states.
The Rivkin Center/CARE Fund Award opportunity is now open. Eligibility is limited to Washington state investigators only. Applications must be submitted by December 1, 2023, at 5 p.m. EST.

Learn more about the application process, eligibility, and award details here.

Currently, there is no effective screening test to catch ovarian cancer in its earliest, most treatable and most survivable stages. With “silent symptoms” that can be easily missed, or mistaken, ovarian cancer often goes undetected until it has reached an advanced stage. That is why about 80 percent of women with ovarian cancer are diagnosed at advanced stages when chances of cure are poor. Ovarian cancer remains the deadliest gynecological cancer.

The Rivkin Center is a Washington nonprofit organization with an accomplished history of funding promising research in ovarian cancer.

CARE Fund looks forward to future partnerships to promote cancer research and to the resulting improvements in health and wellness for Washington’s communities.

Have an application inquiry? Please contact Dr. Jackie Lang at jackie.lang@rivkin.org.